eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | systemic scleroderma |
| Symptom | |hypertension |
| Sentences | 70 |
| PubMedID- 23283858 | Pulmonary artery hypertension associated with systemic scleroderma: correlation among lung pulmonary blood volume, lung perfusion single photon emission computed tomography, and chest computed tomography images. |
| PubMedID- 21066870 | Interstitial lung disease was diagnosed, accompanied by pulmonary arterial hypertension (pah) associated with systemic sclerosis. |
| PubMedID- 21547892 | Objective: to develop a score to estimate the risk of developing pulmonary hypertension (ph) in patients with systemic sclerosis (ssc). |
| PubMedID- 20526641 | Early detection of pulmonary hypertension (ph) in patients with systemic sclerosis (ssc) is essential as it leads to substantial morbidity and mortality irrespective of its etiology. |
| PubMedID- 22105781 | Pulmonary arterial hypertension associated with systemic sclerosis in the czech republic. |
| PubMedID- 23687283 | Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the detect study. |
| PubMedID- 21906161 | Echo doppler predictors of pulmonary artery hypertension in patients with systemic sclerosis. |
| PubMedID- 20044465 | Pulmonary arterial hypertension in systemic sclerosis: a distinctive endotheliopathy. |
| PubMedID- 20425528 | Diagnosis and management of pulmonary hypertension in systemic sclerosis. |
| PubMedID- 20810505 | Prevalence of pulmonary hypertension in systemic sclerosis in european caucasians and metaanalysis of 5 studies. |
| PubMedID- 26479414 | Objective: to compare time to clinical worsening (ttcw) based on initial oral pah therapy in systemic sclerosis (ssc) patients with pulmonary arterial hypertension (pah). |
| PubMedID- 25181620 | Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis. |
| PubMedID- 21965635 | Methods: studies using haq-di and/or sf-36 in patients with pulmonary arterial hypertension (pah) associated with systemic sclerosis (pah-ssc) were identified through a systematic literature review and assessed according to the outcome measures in rheumatology clinical trials (omeract) consensus group criteria. |
| PubMedID- 23042670 | Dyspnea assessment and pulmonary hypertension in patients with systemic sclerosis: utility of the university of california, san diego, shortness of breath questionnaire. |
| PubMedID- 22130820 | Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening. |
| PubMedID- 25036561 | Incidence of pulmonary hypertension in patients with systemic sclerosis and no pulmonary symptoms: is annual echocardiographic screening necessary. |
| PubMedID- 20382500 | Conclusion: hrct-determined severity and extent of pulmonary fibrosis may be helpful in screening for pulmonary hypertension in patients with systemic sclerosis. |
| PubMedID- 20144930 | Pulmonary arterial hypertension associated with systemic sclerosis in patients with functional class ii dyspnoea: mild symptoms but severe outcome. |
| PubMedID- 23547391 | There are data in the literature on the relationship of hyperuricemia with pulmonary arterial hypertension in patients with systemic sclerosis. |
| PubMedID- 23499807 | N-terminal pro-brain natriuretic peptide (nt-probnp), a pro-hormone secreted by the myocardium in response to various stimuli, was found to be correlated with several hemodynamic parameters in pulmonary hypertension associated with systemic sclerosis. |
Page: 1 2